REPORTS OF ADVERSE EVENTS TO BLOOD TRANSFUSION IN SLOVENIA IN 2002

  • Marjeta Potočnik Zavod RS za transfuzijsko medicino Šlajmerjeva 6 1000 Ljubljana
  • Marjeta Maček Zavod RS za transfuzijsko medicino Šlajmerjeva 6 1000 Ljubljana
  • Lidija Lokar Splošna bolnišnica Maribor Ljubljanska 5 2000 Maribor
  • Janja Pajk Splošna bolnišnica Celje Oblakova 5 3000 Celje
  • Erika Kavaš Splošna bolnišnica Murska Sobota Ul. dr. Vrbnjaka 6 9000 Murska Sobota
  • Marija Šeruga Doliška Splošna bolnišnica SB Ptuj Potrčeva 23 2250 Ptuj
  • Lidija Strmčnik Splošna bolnišnica Slovenj Gradec Gosposvetska 1 2380 Slovenj Gradec
  • Ludvika Baraga Žiberna Splošna bolnišnica Novo mesto Šmihelska 1 8000 Novo mesto
  • Slavica Maver Splošna bolnišnica Izola Polje 351 6310 Izola
  • Janka Zavadlav Splošna bolnišnica dr. Franca Derganca 5290 Šempeter pri Novi Gorici
  • Zoja Zalokar Splošna bolnišnica Jesenice C. maršala Tita 112 4270 Jesenice
  • Matjaž Urbajs Zavod RS za transfuzijsko medicino Šlajmerjeva 6 1000 Ljubljana
Keywords: blood transfusion, adverse events, haemovigilance system, safety, quality

Abstract

Background. The risk of severe adverse events to blood transfusion is very low. More frequent are adverse events to transfusion, which are not severe, but must also be treated. Introduction of the haemovigilance system is a way of detecting and analysing them in order to correct their cause and to prevent their recurrence.

Methods. In 2002 we collected data on transfusion adverse events registered by the Blood Transfusion Centre of Slovenia and blood transfusion departments in Slovene general hospitals.

Results. 86 adverse events to transfusion were reported in 2002. The most frequent were non-haemolytic fever (42 cases) and allergic reactions (27 cases). 5 cases of haemolysis and 1 of pulmonary oedema were also reported. 11 cases were not categorised.

Conclusions. We suppose that the collected data is not complete. However, it does give us insight into the clinical part of the transfusion chain. The most frequently registered adverse events in Slovenia are the same as in other countries. The presented data is the beginning of a systematic registration, using standard forms and reporting. Analysis and a followup activities are the basis for improvement of the blood transfusion safety and quality of treatment.

Downloads

Download data is not yet available.

References

Love EM, Jones H, Cohen H et al. Lessons learnt from 5 years of implementation of national haemovigilance system in Europe. In: Strengers PFW, Love EM, Politis C, Lissitchkov T. Basic clinical and organisational requirements for an effective haemovigilance. Proceedings of the ESTM residential course. Sofia: ESTM, 2002: 17–25.

Noel L, Debeir J, Cosson A. The French haemovigilance system. Vox Sang 1998; 74: Suppl. 2: 441–5.

Asher D, Atterburry CLJ, Chapman C et al. Summary of annual report 2000– 2001. In: Strengers PFW, Love EM, Politis C, Lissitchkov T. Basic clinical and organisational requirements for an effective haemovigilance. Proceedings of the ESTM residential course. Sofia: ESTM, 2002: 26–33.

Anon. Priporočilo o pripravi, uporabi in zagotavljanju kakovosti komponent krvi. 9. izd. Ljubljana: Svet Evrope v Strassbourgu, Zavod za transfuzijo krvi, Informacijsko dokumentacijski center Sveta Evrope pri NUK v Ljubljani, 2003: 227–34.

Zakon o preskrbi s krvjo. UL RS, 13. 6. 2000, št. 52; 6943–8.

Evropska direktiva 2002/ /ES Evropskega parlamenta in Sveta za določitev standardov kakovosti in varnosti za zbiranje oz. odvzem, testiranje, predelavo, shranjevanje in distribucijo človeške krvi in sestavin krvi ter dopolnitev Direktive 2001/83/EC.

Potočnik M. Hemovigilanca in varna transfuzija krvi. Zdrav Vestn 2004; 73: 81–4.

Strengers PFW, Faber JC, Salpeteur Ch. Haemovigilance in clinical care: uniform reporting form for serious adverse events. In: Strengers PFW, Love EM, Politis C, Lissitchkov T. Basic clinical and organisational requirements for an effective haemovigilance. Proceedings of the ESTM residential course. Sofia: ESTM, 2002: 109–13.

Faber JC. Haemovigilance procedure in transfusion medicine. Proceedings of the VIII European Congress of the International Society of Blood Transfusion. Istanbul: Society of Blood Transfusion, 2003: 19–26.

Potočnik M. Hemovigilanca. Ljubljana: Zavod za transfuzijsko medicino, Klinični center Ljubljana, 2002: 1–15.

Pravilnik o vsebini vodene dokumentacije o uporabi krvi, krvnih pripravkov in zdravil iz krvi, vključno z biotehnološkimi nadomestki za kri. UL RS, 18.7.2003, št. 70; 10817–8.

Brand BC. The Swiss experience of haemovigilance. Zdravljenje s krvjo. 5. podiplomski seminar. Portorož: Zavod RS za transfuzijsko medicino, Klinični center Ljubljana, ESTM – Evropska šola za transfuzijsko medicino, 2002: 138–47.

Robillard P, Itaj KN, Gameau N. Incidence of adverse reactions in the Quebec s Hemovigilance System 2000–2001. Transfusion 2003; 43: Suppl: S72–040A.

Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30: 583–90.

Danielson CF, Rothenberger S, Wilson S, Miraglia C, McCharty L. Suspected transfusion reactions associated with increase in respiratory rate. Transfusion 2003; 43: Suppl: S73–040A.

How to Cite
1.
Potočnik M, Maček M, Lokar L, Pajk J, Kavaš E, Šeruga Doliška M, Strmčnik L, Baraga Žiberna L, Maver S, Zavadlav J, Zalokar Z, Urbajs M. REPORTS OF ADVERSE EVENTS TO BLOOD TRANSFUSION IN SLOVENIA IN 2002. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];73. Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2437
Issue
Vol 73 (2004): Supplement I
Section
Review


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.